Commerical DHA Supplementation

Stopped early · Not applicable

Conditions studied: Randomized Clinical Trial, Docosahexaenoic Acid, Pregnancy

In brief

The purpose of this study is to compare blood levels of women who take commericially available, low dose docosahexaenoic acid (DHA) dietary supplements in pregnancy with women who do not take supplements.

Key facts

Study ID

NCT05415293

Run by

University of New Mexico

People needed

72

Starts

2011-05-01

Expected to finish

2011-05-01

Last updated by the study team

2024-01-11

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Pregnant
• 34-36 weeks gestational age

You may not qualify if…

• Maternal medical disease
• Gestational diabetes
• Pre-eclampsia
• Fetal anomalies
• Ingestion of DHA or fish oil dietary supplements during the current pregnancy

Where it is running

• University of New Mexico Hospital — Albuquerque, New Mexico, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.